Malter, M. and Fink, G. R. (2016). Therapy of Antibody-Associated Autoimmune Encephalitis. Forschritte Neurol. Psychiatr., 84 (5). S. 281 - 289. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3522

Full text not available from this repository.

Abstract

The identification of an antibody-associated autoimmune encephalitis underlying diverse syndromes, typically comprising epileptic seizures and neuropsychiatric symptoms, and their favorable prognosis, when treated with immunotherapies, is one of the success stories in neurology in recent years. Here we review current widely used therapy regimens in antibody-associated autoimmune encephalitis and the prognosis of the different antibody-associated sub-forms. The main therapeutic instruments encompass tumor therapy (if tumor is detected) and immunotherapies, though recommendations are mainly based on retrospective data analysis. The primary therapeutic goal is complete remission. The degree to which this can be accomplished depends upon the different sub-forms.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Malter, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fink, G. R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-277630
DOI: 10.1055/s-0042-106388
Journal or Publication Title: Forschritte Neurol. Psychiatr.
Volume: 84
Number: 5
Page Range: S. 281 - 289
Date: 2016
Publisher: GEORG THIEME VERLAG KG
Place of Publication: STUTTGART
ISSN: 1439-3522
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
GLUTAMIC-ACID DECARBOXYLASE; ASPARTATE RECEPTOR ENCEPHALITIS; REFRACTORY STATUS EPILEPTICUS; TEMPORAL-LOBE EPILEPSY; FACIOBRACHIAL DYSTONIC SEIZURES; GATED POTASSIUM CHANNEL; LIMBIC ENCEPHALITIS; GAD ANTIBODIES; CASE SERIES; NMDAR-ENCEPHALITISMultiple languages
Clinical Neurology; PsychiatryMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/27763

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item